Corvus Pharmaceuticals, Inc. (CRVS)
13.93
-0.46
(-3.20%)
USD |
NASDAQ |
Sep 08, 16:00
13.93
0.00 (0.00%)
Pre-Market: 08:06
Corvus Pharmaceuticals Market Cap : 1.172B for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.172B |
| September 04, 2026 | 1.210B |
| September 03, 2026 | 1.232B |
| September 02, 2026 | 1.195B |
| September 01, 2026 | 1.200B |
| August 31, 2026 | 1.181B |
| August 28, 2026 | 1.191B |
| August 27, 2026 | 1.238B |
| August 26, 2026 | 1.239B |
| August 25, 2026 | 1.225B |
| August 24, 2026 | 1.185B |
| August 21, 2026 | 1.216B |
| August 20, 2026 | 1.205B |
| August 19, 2026 | 1.295B |
| August 18, 2026 | 1.248B |
| August 17, 2026 | 1.254B |
| August 14, 2026 | 1.253B |
| August 13, 2026 | 1.274B |
| August 12, 2026 | 1.266B |
| August 11, 2026 | 1.239B |
| August 10, 2026 | 1.156B |
| August 07, 2026 | 1.171B |
| August 06, 2026 | 1.166B |
| August 05, 2026 | 1.172B |
| August 04, 2026 | 1.171B |
| Date | Value |
|---|---|
| August 03, 2026 | 1.124B |
| July 31, 2026 | 1.115B |
| July 30, 2026 | 1.109B |
| July 29, 2026 | 1.097B |
| July 28, 2026 | 1.119B |
| July 27, 2026 | 1.086B |
| July 24, 2026 | 1.099B |
| July 23, 2026 | 1.150B |
| July 22, 2026 | 1.176B |
| July 21, 2026 | 1.217B |
| July 20, 2026 | 1.186B |
| July 17, 2026 | 1.253B |
| July 16, 2026 | 1.200B |
| July 15, 2026 | 1.255B |
| July 14, 2026 | 1.259B |
| July 13, 2026 | 1.237B |
| July 10, 2026 | 1.318B |
| July 09, 2026 | 1.362B |
| July 08, 2026 | 1.352B |
| July 07, 2026 | 1.314B |
| July 06, 2026 | 1.276B |
| July 02, 2026 | 1.281B |
| July 01, 2026 | 1.241B |
| June 30, 2026 | 1.256B |
| June 29, 2026 | 1.218B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.747B |
| Alnylam Pharmaceuticals, Inc. | 34.78B |
| Anika Therapeutics, Inc. | 281.58M |
| Savara, Inc. | 1.136B |
| Vericel Corp. | 2.000B |
Market Cap Related Metrics
| Price to Book Value | 5.200 |
| Price | 13.93 |
| Earnings Yield | -4.43% |